Veru outlines new Phase IIb obesity trial and targets interim analysis in Q1 2027 while increasing cash reserves
Veru Inc. · PHARMACEUTICAL PREPARATIONS · Now $2.38
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS